We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$107B
AUM Growth
-$4.88B
Cap. Flow
+$802M
Cap. Flow %
0.75%
Top 10 Hldgs %
28.03%
Holding
4,262
New
46
Increased
1,724
Reduced
2,093
Closed
87

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$78.7M
2
XYZ
Block Inc
XYZ
+$49.3M
3
V icon
Visa
V
+$46.1M
4
AAPL icon
Apple
AAPL
+$45.4M
5
DASH icon
DoorDash
DASH
+$45.1M

Sector Composition

Rank Sector Weight
1 Technology 28.67%
2 Financials 14.43%
3 Healthcare 10.97%
4 Consumer Discretionary 10.82%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAYS icon
3101
Paysign
PAYS
$705M
$98.8K ﹤0.01%
46,587
+2,303
+5% +$6.15K
QUIK icon
3102
QuickLogic
QUIK
$257M
$98.1K ﹤0.01%
19,205
+1,733
+10% +$13K
NNBR icon
3103
NN Inc
NNBR
$311M
$97.8K ﹤0.01%
43,282
-2,181
-5% -$6.26K
THRD
3104
DELISTED
Third Harmonic Bio
THRD
$97.7K ﹤0.01%
28,171
-751
-3% -$3.64K
LKFT
3105
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$97.7K ﹤0.01%
3,888
-935
-19% -$23.6K
BLTE
3106
Belite Bio
BLTE
$6.54B
$95K ﹤0.01%
1,435
NPWR icon
3107
NET Power
NPWR
$134M
$93.7K ﹤0.01%
35,623
+3,375
+10% +$23.8K
LI icon
3108
Li Auto
LI
$12.7B
$93.3K ﹤0.01%
3,703
-4,753
-56% -$122K
GLSI icon
3109
Greenwich LifeSciences
GLSI
$211M
$92.3K ﹤0.01%
9,673
+3,168
+49% +$38.4K
NRDY icon
3110
Nerdy
NRDY
$96.7M
$91.9K ﹤0.01%
64,756
-2,887
-4% -$4.86K
CIG icon
3111
CEMIG Preferred Shares
CIG
$6.01B
$91.9K ﹤0.01%
52,218
-56,379
-52% -$105K
TNGX icon
3112
Tango Therapeutics
TNGX
$4.41B
$91.5K ﹤0.01%
66,806
+1,066
+2% +$2.62K
LCTX icon
3113
Lineage Cell Therapeutics
LCTX
$278M
$91K ﹤0.01%
201,447
+18,092
+10% +$10.6K
ZBIO
3114
Zenas BioPharma
ZBIO
$2.05B
$91K ﹤0.01%
11,514
-27,428
-70% -$215K
STKS icon
3115
The ONE Group
STKS
$53M
$90.7K ﹤0.01%
30,344
+2,854
+10% +$8.98K
GRWG icon
3116
GrowGeneration
GRWG
$90.7M
$90.6K ﹤0.01%
83,886
-5,766
-6% -$7.73K
QIPT
3117
DELISTED
Quipt Home Medical
QIPT
$90.5K ﹤0.01%
38,827
-3,052
-7% -$8.37K
FRGE
3118
DELISTED
Forge Global Holdings
FRGE
$90.2K ﹤0.01%
10,702
-618
-5% -$7.14K
AMTX icon
3119
Aemetis
AMTX
$124M
$89.8K ﹤0.01%
51,641
-3,329
-6% -$7.12K
MKTAY
3120
DELISTED
MAKITA CORP SPONS ADR
MKTAY
$89.6K ﹤0.01%
2,698
EVI icon
3121
EVI Industries
EVI
$180M
$89.5K ﹤0.01%
5,336
+940
+21% +$16.4K
VRA icon
3122
Vera Bradley
VRA
$98.7M
$89.5K ﹤0.01%
39,790
-1,033
-3% -$3.34K
RHLD
3123
Resolute Holdings Management
RHLD
$1.07B
$89.1K ﹤0.01%
+2,843
New +$101K
FLNA
3124
Filana Therapeutics
FLNA
$48.1M
$88.4K ﹤0.01%
58,958
+1,129
+2% +$2.85K
STRW icon
3125
Strawberry Fields REIT
STRW
$190M
$88.3K ﹤0.01%
7,412
+2,098
+39% +$24.3K

Similar funds

RhumbLine Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, RhumbLine Advisers held 4,262 positions worth $107B, down 4.4% from $112B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 3.1%. RhumbLine Advisers opened 46 new positions and exited 87, leaving the 4,262-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2025 buy was Block Inc: 660,293 shares worth $35.9M.
  • RhumbLine Advisers added most to iShares Russell 2000 ETF in Q1 2025, an estimated $78.7M increase.
  • RhumbLine Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $78.8M.
  • RhumbLine Advisers fully exited Aspen Technology Inc in Q1 2025, selling an estimated $19.7M.
  • RhumbLine Advisers's ten largest holdings make up 28% of its $107B portfolio in Q1 2025.
  • RhumbLine Advisers opened 46 new positions and closed 87 in Q1 2025.
  • RhumbLine Advisers's portfolio value fell 4.4% quarter-over-quarter to $107B.

Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.